Company Filing History:
5 out of 13 
2 out of 7 
1 out of 2 Years Active: 2019-2025
Title: Michael P Smolinski: A Trailblazer in Pharmaceutical Innovation
Introduction:
Meet Michael P Smolinski, a brilliant inventor and pharmaceutical researcher hailing from Amherst, NY. With a deep passion for advancing healthcare and drug development, Smolinski has achieved noteworthy success throughout his career. This article explores his latest patents, career highlights, and collaborations, shedding light on his significant contributions to the field of pharmaceuticals.
Latest Patents:
Smolinski has been granted a total of 8 patents, showcasing his aptitude for innovation and problem-solving. Among his recent patents, two stand out for their potential to revolutionize cancer treatment:
1. Acetamido-phenyltetrazole derivatives and methods of using the same:
In this patent, Smolinski discloses compounds of Formula (IA) and their prodrugs, pharmaceutically acceptable salts, pharmaceutical compositions, and methods for their preparation. These compounds exhibit effectiveness in treating disorders where P-glycoprotein and/or cytochrome P450 (e.g., CYP3A4) are modulated, particularly cancers that have developed multi-drug resistance.
2. Polymorphisms of HM30181 mesylate:
Smolinski's innovation focuses on using HM30181 polymorphisms, specifically polymorphism C, to enhance the absorption of cancer chemotherapy drugs like paclitaxel. This patent highlights the physical properties and methods for the preparation and characterization of various HM30181 polymorphisms.
Career Highlights:
Throughout his career, Smolinski has made significant contributions to the pharmaceutical industry. He has held prominent positions in renowned companies such as Athenex, Inc. and Athenex HK Innovative Limited. During his tenure at these organizations, he has played a crucial role in driving innovation and finding novel solutions for complex medical challenges.
Collaborations:
Smolinski's collaborations with outstanding researchers have further bolstered his innovative endeavors. He has worked alongside talented individuals like Sameer Urgaonkar and David G Hangauer, Jr., leveraging their expertise and collective efforts to pioneer transformative pharmaceutical technologies. These collaborations underline the power of teamwork and collaboration in advancing scientific breakthroughs.
Conclusion:
Michael P Smolinski stands as an exceptional inventor and pharmaceutical researcher whose ingenious work has the potential to reshape the field of medicine. His contributions to the treatment of drug-resistant cancers and the enhancement of chemotherapy drug absorption are notable achievements that hold promise for improving patient outcomes. With a track record of innovation and success, Smolinski continues to inspire future generations of inventors and researchers in their quest for advancements in pharmaceuticals and healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.